A new method to estimate doses to the normal tissues after past extended and involved field radiotherapy for Hodgkin lymphoma

Radiotherapy and Oncology

Volumn 114, Issue 2, 2015, Pages 206-211

  Maraldo, Maja V ^a   Lundemann, Michael ^a   Vogelius, Ivan R ^a   Specht, Lena ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dose estimates; Extended field; Hodgkin lymphoma; Involved field; Normal tissues

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; ESOPHAGUS; EXTENDED FIELD; FEMALE; HODGKIN DISEASE; HUMAN; INVOLVED FIELD; LUNG; MALE; MITRAL VALVE; NECK; ORGANS AT RISK; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION FIELD; RADIATION RESPONSE; RISK REDUCTION; SPLEEN; SUBMANDIBULAR GLAND; THYROID GLAND; TRICUSPID VALVE; COMPUTER ASSISTED RADIOTHERAPY; MEDIASTINUM; MIDDLE AGED; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HODGKIN DISEASE; HUMANS; MEDIASTINUM; MIDDLE AGED; ORGANS AT RISK; RADIATION DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; YOUNG ADULT;

EID: 84926164152     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.01.008     Document Type: Article

References (29)

1. H.T. Eich, V. Diehl, and H. Gorgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
2. A. Engert, A. Plutschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma N Engl J Med 363 2010 640 652
3. M. Tubiana, M. Henry-Amar, M. Hayat, K. Breur, B. Werf-Messing, and M. Burgers Long-term results of the E.O.R.T.C. randomized study of irradiation and vinblastine in clinical stages I and II of Hodgkin's disease Eur J Cancer 15 1979 645 657
4. A. Engert, P. Schiller, and A. Josting Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608
5. C. Ferme, H. Eghbali, and J.H. Meerwaldt Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease N Engl J Med 357 2007 1916 1927
6. M.V. Maraldo, M.C. Aznar, I.R. Vogelius, P.M. Petersen, and L. Specht Involved node radiation therapy: an effective alternative in early-stage Hodgkin lymphoma Int J Radiat Oncol Biol Phys 85 2013 1057 1065
7. B.M. Aleman, A.W. van den Belt-Dusebout, and M.L. De Bruin Late cardiotoxicity after treatment for Hodgkin lymphoma Blood 109 2007 1878 1886
8. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors Blood 100 2002 1989 1996
9. De Bruin ML, Sparidans J, van't Veer MB, et al. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes. J Clin Oncol 2009;27:4239-46.
10. S.L. Hancock, M.A. Tucker, and R.T. Hoppe Factors affecting late mortality from heart disease after treatment of Hodgkin's disease JAMA 270 1993 1949 1955
11. M. Feng, J.M. Moran, and T. Koelling Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer Int J Radiat Oncol Biol Phys 79 2011 10 18
12. A.Y.S. Jorgensen, M.V. Maraldo, and N.P. Brodin The effect on esophagus after different radiotherapy techniques for early stage Hodgkin's lymphoma Acta Oncol 52 2013 1559 1565
13. M.V. Maraldo, N.P. Brodin, and M.C. Aznar Estimated risk of cardiovascular disease and secondary cancers with modern highly conformal radiotherapy for early-stage mediastinal Hodgkin lymphoma Ann Oncol 24 2013 2113 2118
14. M.V. Maraldo, P. Brodin, and M.C. Aznar Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment? Int J Radiat Oncol Biol Phys 87 2013 297 303
15. M.V. Maraldo, N.P. Brodin, and M.C. Aznar Doses to head and neck normal tissues for early stage Hodgkin lymphoma after involved node radiotherapy Radiother Oncol 110 2014 441 447
16. P.P. Carbone, H.S. Kaplan, K. Musshoff, D.W. Smithers, and M. Tubiana Report of the committee on Hodgkin's disease staging classification Cancer Res 31 1971 1860 1861
17. H. Eghbali, P. Brice, and G.J. Creemers Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial Blood 106 2005 814
18. C. Ferme, M. Divine, and A. Vranovsky Four ABVD and involved-field radiotherapy in unfavorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-U trial Blood 106 2005 813
19. A. Bufacchi, B. Nardiello, R. Capparella, and L. Begnozzi Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters Radiat Oncol 8 2013 164
20. J.O. Deasy, A.I. Blanco, and V.H. Clark CERR: a computational environment for radiotherapy research Med Phys 30 2003 979 985
21. C.W. Taylor, A. Nisbet, P. McGale, and S.C. Darby Cardiac exposures in breast cancer radiotherapy: 1950s-1990s Int J Radiat Oncol Biol Phys 69 2007 1484 1495
22. C.W. Taylor, A. Nisbet, and P. McGale Cardiac doses from Swedish breast cancer radiotherapy since the 1950s Radiother Oncol 90 2009 127 135
23. L.B. Travis, M. Gospodarowicz, and R.E. Curtis Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease J Natl Cancer Inst 94 2002 182 192
24. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
25. F.E. van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease J Natl Cancer Inst 95 2003 971 980
26. E.S. Koh, T.H. Tran, and M. Heydarian A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk Radiat Oncol 2 2007 13
27. A. Ng, K.K. Brock, M.B. Sharpe, J.L. Moseley, T. Craig, and D.C. Hodgson Individualized 3D reconstruction of normal tissue dose for patients with long-term follow-up: a step toward understanding dose risk for late toxicity Int J Radiat Oncol Biol Phys 84 2012 e557 e563
28. D. Vordermark, I. Seufert, and F. Schwab 3-D reconstruction of anterior mantle-field techniques in Hodgkin's disease survivors: doses to cardiac structures Radiat Oncol 1 2006 10
29. L. Specht, J. Yahalom, and T. Illidge Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the International Lymphoma Radiation Oncology Group (ILROG) Int J Radiat Oncol Biol Phys 89 2014 854 862